| Dr Karl Michael Duerr, MD | |
|
300 W 27th St, Lumberton, NC 28358-3075 | |
| (910) 671-5000 | |
| Not Available |
| Full Name | Dr Karl Michael Duerr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 34 Years |
| Location | 300 W 27th St, Lumberton, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184644205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 9300089 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Okaloosa Medical Center | Crestview, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Floridian Emergency Specialists Llc | 3375682891 | 24 |
News Archive
Patients with type 1 diabetes mellitus (T1DM) often need to modify their eating habits, but many youths with T1DM do not consume a healthful diet. To learn more about the challenges their parents may face in providing them with a more healthful diet, researchers set out to discover the availability of healthier food options and the price difference of the food items at stores frequented by families in northeastern Kansas and western Missouri.
XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.
A new study by researchers at the University of Maryland has revealed a 46 percent drop in reported errors after drugmakers in October 2007 removed from the market a number of over-the-counter cough and cold medications labeled for children under the age of 2.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
The latest report from a 30-year study of families at high- and low-risk for depression reveals that the offspring of depressed parents have a higher risk for depression, morbidity and mortality that persists into middle age.
› Verified 5 days ago
| Entity Name | Floridian Emergency Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710210695 PECOS PAC ID: 3375682891 Enrollment ID: O20091123000274 |
News Archive
Patients with type 1 diabetes mellitus (T1DM) often need to modify their eating habits, but many youths with T1DM do not consume a healthful diet. To learn more about the challenges their parents may face in providing them with a more healthful diet, researchers set out to discover the availability of healthier food options and the price difference of the food items at stores frequented by families in northeastern Kansas and western Missouri.
XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.
A new study by researchers at the University of Maryland has revealed a 46 percent drop in reported errors after drugmakers in October 2007 removed from the market a number of over-the-counter cough and cold medications labeled for children under the age of 2.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
The latest report from a 30-year study of families at high- and low-risk for depression reveals that the offspring of depressed parents have a higher risk for depression, morbidity and mortality that persists into middle age.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karl Michael Duerr, MD 2600 N Elm St, Lumberton, NC 28358-3011 Ph: (910) 272-3051 | Dr Karl Michael Duerr, MD 300 W 27th St, Lumberton, NC 28358-3075 Ph: (910) 671-5000 |
News Archive
Patients with type 1 diabetes mellitus (T1DM) often need to modify their eating habits, but many youths with T1DM do not consume a healthful diet. To learn more about the challenges their parents may face in providing them with a more healthful diet, researchers set out to discover the availability of healthier food options and the price difference of the food items at stores frequented by families in northeastern Kansas and western Missouri.
XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.
A new study by researchers at the University of Maryland has revealed a 46 percent drop in reported errors after drugmakers in October 2007 removed from the market a number of over-the-counter cough and cold medications labeled for children under the age of 2.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
The latest report from a 30-year study of families at high- and low-risk for depression reveals that the offspring of depressed parents have a higher risk for depression, morbidity and mortality that persists into middle age.
› Verified 5 days ago
Michael Bruss, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 | |
Erin Broderick, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 West 27th Street, Southeastern Health, Lumberton, NC 28359 Phone: 910-272-1478 Fax: 910-671-5392 | |
Dr. Bruce S. Whitman, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 | |
Jenna Santiago-wickey, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-272-1478 Fax: 910-671-5392 | |
Dr. Aleksandr Pevtsov, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-735-8783 | |
Douglas Nederostek, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 |